|4Aug 9, 6:06 PM ET

DAMASIO JOSEPH LUIS JR 4

4 · Biostage, Inc. · Filed Aug 9, 2022

Insider Transaction Report

Form 4
Period: 2022-08-08
DAMASIO JOSEPH LUIS JR
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-08-08+116,156116,156 total
    Exercise: $5.00Exp: 2032-08-08Common Stock, par value $0.01 per share (116,156 underlying)
Footnotes (1)
  • [F1]Subject to continued employment through the applicable vesting dates, these shares vest in four equal annual increments on each anniversary of the grant date.

Documents

1 file
  • 4
    tm2222955-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT